Understanding these patterns prevents mistaking normal progression for problems requiring intervention
Podcast: Embed Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | Pandora | iHeartRadio | TuneIn | Deezer | RSS Welcome back to the CardioNerds Cardiovascular Prevention Series, where we are continuing our discussion of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs)
While emerging research suggests gut bacteria may influence metabolic health, the evidence supporting probiotics for meaningful weight loss remains limited and preliminary
27 New Indications : A 505(b)(2) sponsor can focus on a carve-out indication, such as obstructive sleep apnea or MASH (metabolic dysfunction-associated steatohepatitis), where the innovators method-of-use patents for obesity or diabetes do not apply
When prescribed as part of a supervised program, GLP-1 therapies may help support steadier eating patterns, improved fullness cues, and long-term lifestyle changes
Its conclusion is caution and closer provider involvement rather than a blanket answer